These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3442988)

  • 1. Dialysate temperature and complement activation.
    Maggiore Q; Enia G; Catalano C; Mundo A; Misefari V
    Contrib Nephrol; 1987; 59():72-9. PubMed ID: 3442988
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellulose membranes--time for a change?
    Henderson LW; Chenoweth DE
    Contrib Nephrol; 1985; 44():112-26. PubMed ID: 3872769
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of complement activation by hemodialysis membranes.
    Cheung AK; Henderson LW
    Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
    [No Abstract]   [Full Text] [Related]  

  • 4. Compartmental distribution of complement activation products in artificial kidneys.
    Cheung AK; Chenoweth DE; Otsuka D; Henderson LW
    Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of membrane biocompatibility.
    Colton CK
    Contrib Nephrol; 1987; 59():110-25. PubMed ID: 3502085
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM; Breillatt J; Lazarus JM; Port FK
    N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of blood cooling on cuprophan-induced anaphylatoxin generation.
    Maggiore Q; Enia G; Catalano C; Misefari V; Mundo A
    Kidney Int; 1987 Dec; 32(6):908-11. PubMed ID: 3430969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
    Freyria AM; Leitienne P; Veysseyre CN; Bringuier JP; Traeger J
    Int J Artif Organs; 1988 Mar; 11(2):111-8. PubMed ID: 3259552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modification of cellulose that facilitates the control of complement activation.
    Johnson RJ; Lelah MD; Sutliff TM; Boggs DR
    Blood Purif; 1990; 8(6):318-28. PubMed ID: 2151203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation during hemodialysis: laboratory evaluation of hemodialyzers.
    Chenoweth DE; Henderson LW
    Artif Organs; 1987 Apr; 11(2):155-62. PubMed ID: 3496072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms and activation of granulocytes and complement with two dialysis membranes.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
    Wiegmann TB; MacDougall ML; Diederich DA
    Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodialysis induced activation of complement relates also to individual responsiveness.
    Knudsen F; Nielsen AH; Pedersen JO; Jersild C
    Int J Artif Organs; 1985 Jul; 8(4):233-4. PubMed ID: 4055100
    [No Abstract]   [Full Text] [Related]  

  • 15. Biocompatibility of artificial organs: an overview.
    Henderson LW; Chenoweth D
    Blood Purif; 1987; 5(2-3):100-11. PubMed ID: 3304344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellulose acetate hemodialysis membranes are better tolerated than Cuprophan. A difference in complement and neutrophil activation.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Contrib Nephrol; 1984; 37():78-82. PubMed ID: 6713881
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukopenia and complement activation induced by different dialysis membranes.
    Man NK; Tien NQ; Lesavre P; Funck-Brentano JL
    Contrib Nephrol; 1984; 37():142-8. PubMed ID: 6713867
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of different blood parameters for evaluation of complement activation during hemodialysis.
    Gardinali M; Cicardi M; Bergamaschini L; Frangi D; Franzinelli M; Anelli A; Brancaccio D; Agostoni A
    Trans Am Soc Artif Intern Organs; 1985; 31():42-4. PubMed ID: 3837483
    [No Abstract]   [Full Text] [Related]  

  • 20. Biocompatibility of different hemodialysis and plasmapheresis membranes.
    Jørstad S
    Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.